Selena Gomez, founder of Rare Impact Fund

About Us Our Founder

Recording artist, actress, producer, entrepreneur, and philanthropist, Selena Gomez has been a leading voice in mental health for over a decade. With unflinching honesty, she shared her personal struggles in the 2022 film My Mind & Me, and consciously works to destigmatize the subject by discussing her mental health journey openly in the media. Selena’s experiences inspired her to establish her beauty brand, Rare Beauty, as a safe, welcoming community for young people everywhere. With The Rare Impact Fund, she aims to create real and lasting change.

As part of this effort, 1% of all Rare Beauty sales are donated to the Rare Impact Fund. In addition, the Rare Impact Fund raises funds from philanthropic foundations, individuals, corporate partners, and the community.

What We Do The Rare Impact Fund is:

Mobilizing $100 million in philanthropic dollars to distribute to trusted organizations that align with our vision and mission
Sourcing and vetting non-profit partners in mental health to reach more young people and inform the field
Connecting our donor community to a growing cohort of mental health organizations to increase social capital

Raising awareness and de-stigmatizing youth mental health

To Purchase Semaglutide Without Prescription Visit Our Pharmacy ↓




Improved Patient Outcomes in General Well-being



Implementing healthy lifestyle changes is essential for maximizing the benefits of semaglutide in diabetes management. Semaglutide, on the other hand, has demonstrated substantial and sustained weight loss in clinical trials, thanks to its ability to influence appetite control and energy balance directly. By addressing both insulin resistance and appetite regulation, semaglutide offers patients a comprehensive approach to managing their condition. Through this mechanism, individuals may find it easier to adhere to weight-loss plans, making semaglutide a powerful ally in the battle against obesity. This is due to its dual benefits in managing blood sugar levels and contributing to weight loss, which could lead to reduced healthcare costs overall. Semaglutide, a member of the GLP-1 receptor agonists class, was initially developed for managing type 2 diabetes. Monitoring carbohydrate intake and adopting a meal plan that aligns with individual health goals will create a synergistic effect on blood glucose control.



Future Prospects: Semaglutide and Ongoing Research in Obesity



By addressing these aspects of glucose metabolism, GLP-1 agonists have become crucial tools in managing type 2 diabetes and, more recently, obesity. Participants frequently report a reduction in blood sugar levels, leading to better glycemic control, which is especially significant for those managing diabetes. However, this journey isn't without its hurdles. This results in significant weight reduction over time. These drugs work by enhancing glucose-dependent insulin secretion, curbing glucagon release, and slowing gastric emptying. These effects often subside as the body adjusts to the medication. This distinguishes it in the treatment landscape, offering boosted control over both glucose levels and weight, making it a valuable option for many patients.



Positive Impact on Liver Health and Fat Reduction



Upon administration, it sends signals to the brain to enhance [satiety], reducing hunger and leading to a [caloric] deficit. As research surrounding semaglutide progresses, scientists are exploring new applications beyond its current weight management uses. Semaglutide, a novel glucagon-like peptide-1 (GLP-1) analog, operates through a multifaceted approach to combat obesity. When comparing semaglutide to other weight loss treatments, one can appreciate its unique advantages. As a novel GLP-1 receptor agonist, semaglutide plays a pivotal role in managing type 2 diabetes by improving glycemic control and promoting weight loss. Semaglutide has emerged as a promising player in the landscape of obesity treatment. As this class of medication continues to evolve, understanding their nuances is essential for healthcare professionals and patients alike.



Comparing Semaglutide with Traditional Weight Loss Methods



Semaglutide is an injectable medication initially developed to treat type 2 diabetes but has shown impressive results for weight loss. In comparison, other GLP-1 agonists have also been beneficial, but some patients voice a distinct preference for semaglutide due to its once-weekly dosing convenience. Studies have revealed that it functions by mimicking the GLP-1 hormone, effectively reducing appetite and increasing satiety. Semaglutide's impact extends far beyond simply managing blood sugar levels. The compound medication appears to work by enhancing cardiovascular functions, likely due to weight loss and improved metabolic control, both of which reduce stress on the heart and blood vessels. Recently, its impact on heart health has garnered attention. Patients across the globe are sharing remarkable journeys, showcasing how semaglutide has transformed their weight loss experiences.



Overview of Semaglutide: Mechanism and Benefits



Many who have struggled with obesity for years now report feeling liberated, citing improvements in energy levels, mobility, and mental well-being. Fortunately, the availability of semaglutide has improved over time, with most PBMs listing it as a covered option, enhancing its accessibility in the healthcare market. Unlike many other treatments, semaglutide has demonstrated impressive efficacy, with participants experiencing significant weight loss. These perks make it a notable option in the weight management arsenal. This makes it a compelling option for clinicians looking to script the most effective treatment plans for their patients. One of its standout features is its efficacy in weight management, making it a popular choice not just for diabetes control but also for addressing obesity. Preliminary studies indicate that it may have potential benefits for individuals struggling with types 2 diabetes and other metabolic disorders.



The Rising Popularity of Semaglutide for Weight Management



Some patients describe metformin’s effects as the “slow and steady” option but find semaglutide offers a rapid improvement in glucose control that feels almost like an elixir, providing them more immediate relief. Consultation with a healthcare professional is crucial when considering expenses and benefits to find the most suitable GLP-1 agonist for an individual's needs. Within months, Sarah saw dramatic weight loss, ultimately losing over 50 pounds. As more individuals grapple with obesity and its associated health risks, this medication offers a beacon of hope, appealing to both healthcare providers and patients alike. Available in various forms, including daily and weekly scripts, they cater to different patient needs. It offers a novel approach by mimicking the incretin hormones that are involved in appetite regulation and insulin secretion, making it a dual purpose treatment for those struggling with their weight. Cost is another crucial factor, as insurance coverage and out-of-pocket costs vary.



Semaglutide’s Unique Mechanism of Action in Weight Loss



One notable effect is its ability to foster a healthier metabolic environment by addressing multiple facets of metabolic syndrome. Unlike many other GLP-1 receptor agonists requiring daily doses, semaglutide offers the flexibility of weekly injections, greatly reducing the "Pill Burden" for patients. Some patients experience these issues stat but often find they diminish over time. Unlike some of its peers, semaglutide is associated with a lower risk of gastrointestinal issues over time, which can enhance patient adherence and overall treatment outcomes. Once administered, semaglutide binds to and activates the GLP-1 receptors in the pancreas, thereby stimulating insulin release and suppressing the secretion of glucagon, another hormone involved in blood sugar regulation. Unlike traditional meds, they also slow gastric emptying and reduce appetite, contributing to weight loss. As diabetes research continues to evolve, semaglutide is poised to play a pivotal role in future management strategies.



Cost Considerations: Semaglutide Versus Other Options



While semaglutide has demonstrated remarkable efficacy in promoting weight loss, it's essential to be aware of potential side effects that may accompany its use. Notably, this drug is typically covered under various formulary plans, but patients often require a prior auth to get the medication approved. One of the critical factors influencing the choice of semaglutide is its cost and availability. Technically, semaglutide is much more than just another [script] in the battle against obesity. In contrast, many other GLP-1 agonists remain limited to subcutaneous injections. Understanding these effects is crucial for a successful journey with semaglutide. This action disrupts the typical cycle associated with obesity, where traditional treatments have often [fell short].



Hormonal Interactions: Appetite Control and Satiety



Testimonials also revealed that some faced fewer side effects, which improved their quality of life. Users often report significant weight loss and improved metabolic profiles, which are crucial benefits for those grappling with cardiovascular issues. Patients often report fewer mood swings and a greater sense of stability in their daily lives, making it a valuable tool in holistic health strategies. Selecting the most suitable GLP-1 agonist hinges on individual health needs and lifestyle preferences. For instance, While beta-blockers effectively manage high blood pressure and reduce heart strain, semaglutide addresses the broader spectrum of metabolic health. Semaglutide, like its counterparts, can cause gastrointestinal issues, including nausea, vomiting, and diarrhea. Clinical outcomes have illustrated that semaglutide may offer superior efficacy, wich is particularly evident in its ability to significantly reduce HbA1c levels and support sustainable weight loss.



Side Effects: How Semaglutide Stacks up



Traditional methods like diet, exercise, and over-the-counter (OTC) medications often require a significant amount of effort and commitment, yet may yield limited results. This new approach offers a potential dual benefit, particularly for patients at risk of both diabetes and cardiovascular disease. This flexibility can improve patient adherance and satisfaction. Clinical trials reveal that semaglutide not only enhances glycemic control but also significantly aids in weight reduction, an area where many of its peers struggle to show pronounced results. Semaglutide has emerged as a groundbreaking treatment for obesity, rapidly gaining attention for its impressive weight loss results. The effectiveness of GLP-1 receptor agonists, combined with their multifaceted benefits, makes them a top pick in diabetes treatment. This mechanism operates primarily through the stimulation of insulin release in response to elevated blood sugar levels while simultaneously suppressing glucagon release, which contributes to glucose production in the liver.



Buy Ocuflox No Prescription
Online Advair No Prescription
Order Glucophage Online

Driving more dollars to an underfunded field

Accord­ing to recent data, 62% of young people who have struggled with their mental health are not getting the complete care they need.

Recent data also tells us that global governments are allocating only 2% of their budgets toward mental health, and only 34% of responding countries indicated that their financial needs had been met.

As global governments come up short, private donations are proving to be essential. Yet just 0.5% of global health philanthropic spend went to mental health in 2021, according to WHO.

The Rare Impact Fund bridges the gap between donors and non-profits to generate much-needed financial support for mental health. Chief among priorities is supporting non-profits providing services to underrepresented populations as we recognize that mental health disparities among young people who are Black, Indigenous, and/or people of color (BIPOC), and LGBTQ+. are severely under resourced. The Rare Impact Fund portfolio is currently 40% BIPOC-led; globally, 20% of our non-profit partners are managed by leaders of color.

The Rare Impact Fund is shifting donor attention to non-profits making a tangible difference in the mental health space, ultimately changing the way they allocate funding.

Expanding access to mental health resources through data

Access to care is a chal­lenge for Gen Z, too. A 2022 Kaiser Fam­i­ly Foun­da­tion sur­vey found that almost half (47%) of young adults ages 18 to 29 did not get men­tal health care in the past year when they thought they might need it, with cost cit­ed among the top bar­ri­ers.

The Rare Impact Fund collects and analyzes quantitative and qualitative data from our non-profit partners to inform our approach to delivering grants and resources.

We monitor the progress of our non-profit partners to assess ways to optimize their impact. This approach to measurement provides donors and prospective partners insight into the most powerful ways to deploy funding. Our aim is to continue expanding access to youth mental health resources by stretching each dollar to its maximum potential.